Last reviewed · How we verify
Itolizumab [Bmab 600]
At a glance
| Generic name | Itolizumab [Bmab 600] |
|---|---|
| Also known as | Bmab600, Itolizumab |
| Sponsor | Equillium |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Itolizumab [Bmab 600] CI brief — competitive landscape report
- Itolizumab [Bmab 600] updates RSS · CI watch RSS
- Equillium portfolio CI